指南与共识呼吸衰竭与机械通气重症综合管理与镇静镇痛

重症新型冠状病毒肺炎患者呼吸治疗中预防医院内传播的专家共识

[Expert consensus on preventing nosocomial transmission during respiratory care for critically ill patients infected by 2019 novel coronavirus pneumonia].
指南 / 共识 · Zhonghua Jie He He Hu Xi Za Zhi · 2020-01-01
一句话结论专家共识建议对危重症COVID-19患者呼吸治疗时采取标准防护、患者隔离及一系列减少气溶胶传播的操作调整,以降低医护人员感染风险。

该专家共识针对危重症COVID-19患者呼吸治疗中的医院内传播风险制定防范建议。截至共识撰写时已有超过1700例临床医护人员感染,气管插管、简易呼吸器辅助通气、无创正压通气、高流量鼻导管、气管镜、吸痰和转运等被视为高危操作。共识基于现有证据及国内资源条件,提出标准防护与患者隔离、高流量鼻导管治疗时患者戴口罩、呼吸机回路与过滤器配置、插管时镇静与肌松及套囊压力25-30 cmH2O、密闭式吸痰、呼气端过滤器等措施,旨在降低医护人员感染风险同时为患者提供最佳治疗。

要点

  • 对危重症COVID-19患者呼吸治疗时执行标准预防与防护,并实施患者隔离。
  • 高流量鼻导管治疗期间让患者佩戴口罩;无创通气避免使用面罩上带呼气孔的面罩。
  • 气管插管时使用镇静与肌松,套囊压力维持25-30 cmH2O(1 cmH2O=0.098 kPa)。
  • 推荐使用密闭式吸痰管,可连续使用一周;推荐双回路加热导丝管路,仅在可见污染时更换。
  • 自主呼吸试验推荐使用压力支持通气(PSV),避免用T管;雾化时自主呼吸患者推荐干粉吸入器、带储雾罐的定量吸入器,通气患者推荐振动网孔雾化器并在呼气端加过滤器。

适用人群与场景

  • 危重症新型冠状病毒肺炎(COVID-19)患者,需接受呼吸治疗(如气管插管、无创通气、高流量鼻导管、气管镜、吸痰、转运等)的场景。

处置流程与药物剂量

  • 执行标准预防与防护,并对患者实施隔离。
  • 高流量鼻导管治疗期间让患者佩戴口罩。
  • 使用双回路呼吸机并在呼吸机出口处放置过滤器;或单回路呼吸机使用热湿交换器(HME)替代加热湿化,HME置于呼气口与面罩之间;避免使用面罩上带呼气孔的面罩。
  • 在简易呼吸器与面罩或人工气道之间放置过滤器。
  • 自主呼吸患者行气管镜检查时给患者佩戴口罩;接受无创通气的患者行气管镜检查时使用带气管镜孔的特殊面罩。
  • 气管插管时使用镇静与肌松,套囊压力维持在25-30 cmH2O(1 cmH2O=0.098 kPa)。
  • 推荐使用密闭式吸痰管,可连续使用一周。
  • 推荐使用双回路加热导丝管路,仅在可见污染时更换。

研究设计与关键结果

  • 共识指出已有超过1700例临床医护人员感染新型冠状病毒肺炎;气管插管、简易呼吸器辅助通气、无创正压通气、高流量鼻导管、气管镜检查、吸痰及转运等呼吸治疗被视为医院内传播高危因素。

证据类型、等级与局限

  • 证据类型:专家共识;基于现有证据及国内资源条件制定;局限:原文未报告局限性。

对床旁实践的改变

  • 作者建议对危重症COVID-19患者呼吸治疗时执行标准预防与防护及患者隔离,以降低医护人员感染风险同时为患者提供最佳治疗。
  • 作者建议高流量鼻导管治疗时患者戴口罩、插管时使用镇静与肌松并维持套囊压力25-30 cmH2O、使用密闭式吸痰管(可用一周)、双回路加热导丝管路仅在可见污染时更换、自主呼吸试验用PSV而避免T管、雾化时按患者类型选择装置并在呼气端加过滤器。

指南或共识出处

  • 重症新型冠状病毒肺炎患者呼吸治疗中预防医院内传播的专家共识(Zhonghua Jie He He Hu Xi Za Zhi)

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Definite evidence has shown that the novel coronavirus (COVID-19) could be transmitted from person to person, so far more than 1 700 bedside clinicians have been infected. A lot of respiratory treatments for critically ill patients are deemed as high-risk factors for nosocomial transmission, such as intubation, manual ventilation by resuscitator, noninvasive ventilation, high-flow nasal cannula, bronchoscopy examination, suction and patient transportation, etc, due to its high possibility to cause or worsen the spread of the virus. As such, we developed this consensus recommendations on all those high-risk treatments, based on the current evidence as well as the resource limitation in some areas, with the aim to reduce the nosocomial transmission and optimize the treatment for the COVID-19 pneumonia patients. Those recommendations include: (1)Standard prevention and protection, and patient isolation; (2)Patient wearing mask during HFNC treatment; (3)Using dual limb ventilator with filters placed at the ventilator outlets, or using heat-moisture exchanger (HME) instead of heated humidification in single limb ventilator with HME placed between exhalation port and mask; avoid using mask with exhalation port on the mask; (4)Placing filter between resuscitator and mask or artificial airway; (5)For spontaneous breathing patients, placing mask for patients during bronchoscopy examination; for patients receiving noninvasive ventilation, using the special mask with bronchoscopy port to perform bronchoscopy; (6)Using sedation and paralytics during intubation, cuff pressure should be maintained between 25-30 cmH(2)O(1 cmH(2)O=0.098 kPa); (7)In-line suction catheter is recommended and it can be used for one week; (8)Dual-limb heated wire circuits are recommended and only changed with visible soiled; (9)For patients who need breathing support during transportation, placing an HME between ventilator and patient; (10)PSV is recommended for implementing spontaneous breathing trial (SBT), avoid using T-piece to do SBT. When tracheotomy patients are weaned from ventilator, HME should be used, avoid using T-piece or tracheostomy mask. (11)Avoid unnecessary bronchial hygiene therapy; (12) For patients who need aerosol therapy, dry powder inhaler metered dose inhaler with spacer is recommended for spontaneous breathing patients; while vibrating mesh nebulizer is recommended for ventilated patients and additional filter is recommended to be placed at the expiratory port of ventilation during nebulization.

自首例新型冠状病毒肺炎确诊以来,已有大量人传人的病例,其中超过1 700例医护人员遭受了感染。对危重症患者进行呼吸治疗时有大量高危操作,例如气管插管、简易呼吸器辅助通气、无创正压通气、高流量鼻导管治疗、气管镜检查、吸痰以及转运等均可引起或加重患者气道内呼出病毒的大量传播。因此,我们根据目前最佳证据以及国内现有条件制定了本防范建议,旨在降低医护人员感染风险的同时为患者提供最佳治疗。.

来源:Zhonghua Jie He He Hu Xi Za Zhi,查看原文。版权归原作者所有。

参考来源

  1. [Expert consensus on preventing nosocomial transmission during respiratory care for critically ill patients infected by 2019 novel coronavirus pneumonia]. Zhonghua Jie He He Hu Xi Za Zhi. 2020. PMID: 32294813. doi:10.3760/cma.j.cn112147-20200304-00239

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。